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Abstract
The increase in population growth rate warrants the development of additional contraceptive
methods that are widely acceptable, free from side effects and less expensive.
Immunocontraception, and in particular the targeting of antibodies to gamete-specific antigens
implicated in sperm egg binding and fertilization, offers an attractive approach to control fertility.
The development of a contraceptive vaccine based on sperm antigen represents a promising
approach to contraception. In mammals, fertilization is completed by the direct interaction of
sperm and egg, a process mediated primarily by sperm surface proteins. Sperm have proteins that
are unique, cell specific, immunogenic and accessible to antibodies. A few of the sperm specific
proteins have been isolated and characterized. The antibodies raised against the sperm specific
antigens have proved to be extremely effective at reducing sperm-egg interaction in vitro; fertility
trials in sub-human primates would eventually prove the effectiveness of the sperm antigens in
terms of contraceptive efficacy.
Introduction
The rapidly expanding global population has turned the
attention of family planning and associated reproductive
health programmes and providers towards providing safe
and reliable method that can be used to limit family size.
The human population is projected to exceed a phenom-
enal 10 billion by the year 2050 AD. Further, major
increase in human population will take place in develop-
ing countries as compare to developed countries. There-
fore, it is necessary to develop new, safer, effective and
more economical method of contraception. As a novel
concept, contraceptive vaccines have been proposed as
one of the possible strategy for controlling fertility. Both
gametes (sperm and oocyte) have proteins on the surface
that are unique, cell specific, immunogenic and accessible
to antibodies. Immunological interaction with such mol-
ecules can cause block of sperm penetration and thus fer-
tilization. The present article will focus on the present
status of the development of contraceptive vaccine(s)
based on protein, derived from sperm cell.
Development of vaccine based on sperm antigen repre-
sents a promising approach to contraception [1]. It has
been demonstrated that sperm cell has both isoantigens/
autoantigens [2] potential to generate an immunological
response in both men and women, which is capable of
causing infertility. Experimental evidence demonstrating
reduction in fertility has been documented using prepara-
tion of autologus or isologus sperm resulting in circulat-
ing anti-sperm antibody. Up to 70% of vasectomized men
form anti-sperm antibodies and 2–30% of infertility may
be associated with the presence of circulating anti-sperm
antibodies in the male or female subject of an infertile
couple [3]. For developing sperm based vaccine, whole
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sperm cell cannot be used to immunize because sperm as
a cell share common protein with somatic cell [4]. There-
fore only those proteins, which are, sperm specific, can be
used to develop as a candidate molecule for immunocon-
traception.
In mammals, fertilization is completed by the direct inter-
action of sperm and egg, a process mediated primarily by
gamete surface proteins. Fertilization is a complex process
requiring the sperm to under go a cascade of events
including capacitation, acrosome reaction, binding to
zona pellucida (ZP), penetration through ZP, and fusion
with plasma membrane of the oocyte [5]. Therefore, an
essential task in the study of sperm-egg interaction is an
exploration of the capabilities of a distinct set of surface
proteins, which are gamete specific. The sperm ZP binding
is pivotal tissue and species-specific step of the fertiliza-
tion process, and molecules involved in this event consti-
tute attractive candidate for the contraceptive vaccine
development.
Discussion
The development of male gamete, the spermatozoa is a
unique and probably one of the most complex differenti-
ation processes in higher eukaryotes. Though the forma-
tion of a fully functional sperm involves a series of steps
occurring in different parts of the testis, the main act of
spermatogenesis occurs within the seminiferous tubules.
The processes of spermatogenesis results in highly special-
ized cell structures such as the head and the flagellum. The
sperm head constitutes sperm nucleus and the acrosome
surrounded by moderate amount of cytoskeletal compo-
nent and cytoplasm. The flagellum mainly consists of
cytoskeletal structures, including the axoneme, the mito-
chondria sheath, the outer dense fiber and the fibrous
sheath. Application of a sperm specific protein in the
development of a contraceptive vaccine is contingent
upon its sperm specificity, involvement in fertility. A few
of the sperm specific antigens have been isolated and
characterized by biochemical and immunological tech-
niques and genes encoding for some of these antigen have
been cloned and sequenced [6]. Notable among these are
LDH-C4 [7], PH-20 [8], SP-10 [9], SP-17 [10], FA-1 [11],
FA-2 [12], NZ-1 [13], HSS now referred as SPAG9 [14], HI
now referred as AKAP-4 [15], rSMP-B [16], SAMP14 [17],
SAMP32 [18], TSA-1 [19], CV-1 [20].
Anti-sperm antibodies in infertile subjects have been
shown to be associated with infertility [3]. In our labora-
tory we have screened panel of sera from infertile women.
In immunoblots, one of the major and more frequently
identified band around 71 kDa protein in human sperm
extract was identified by serum from infertile women who
had anti-sperm antibodies, who was otherwise healthy,
had normal endocrine profiles and no fallopian tube con-
striction. This serum had neither autoimmune factors nor
reactivity with any other human somatic tissues. Anti-71
kDa antibodies showed cross reactivity with other species
of sperm, further demonstrated inhibition of sperm
attachment to oocytes in an in vitro mouse system. In an
attempt to identify a candidate protein molecule having
specific function in sperm or sperm-egg interaction per se,
exclusively expressed in testis, a testis cDNA expression
library was screened using polyclonal antibodies against
sperm proteins showing head to head sperm agglutina-
tion and surface localization on live human sperm [14]. A
novel gene coding for human sperm surface protein
SPAG9 (Sperm associated antigen 9) was cloned. Tissue
specific expression studies demonstrated the presence of
SPAG9 transcript only in the testis [14]. Further, studies
are in progress to examine the role of the SPAG9 gene
product during reproduction.
Sperm surface PH-20 antigen has been cloned and studied
in a number of species including the guinea pig [21], rat
[22], mouse [21], horse [23], macaque and human [24].
PH-20/2B1 antigen appears to be a bi-functional sperm
plasma membrane protein. Firstly, its hyaluronidase
activity allows acrosome intact sperm to penetrate the
cumulus cell layer surrounding the oocyte [25] and sec-
ondly, it appears to be required for acrosome-reacted
sperm to bind to the zona pellucida [26]. Antibodies gen-
erated against PH-20 and 2B1 significantly reduce sperm-
zona pellucida binding in vitro assay [27,28]. The immu-
nization trials in both male and female guinea pigs were
reported to lead to infertility in all immunized animals
[29]. However, it has subsequently been shown that
autoimmune orchitis was induced in the male guinea pigs
with the resultant infertility attributable to the absence of
sperm in the epididymis [30]. Further, immunological
response of female macaques to PH-20 sperm protein fol-
lowing injection of recombinant protein or synthesized
peptides was studied [31]. It was reported that antigens
derived from synthesized peptides and recombinant pro-
teins representing selected regions of PH-20 molecule
mounted an immune response and the circulating anti-
bodies from immunized animals recognized macaque
sperm surface PH-20 on western blot and were shown by
indirect immunofluorescence to bind to the surface of
macaque sperm. This data suggested that the selected
regions of PH-20 molecule could be used as vaccine com-
ponent.
SP-10 is a sperm-specific acrosomal protein that was first
identified in the human using a monoclonal antibody [9]
and subsequently cloned and sequenced in human [32],
mouse [33], fox [34], baboon and macaque [35]. Immu-
nological studies have also identified SP-10 on bovine
and porcine sperm. Antibodies to SP-10 inhibit bovine in
vitro fertilization by reducing sperm-zona secondary bind-Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/10
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ing [36] and a monoclonal antibody HS 63, which was
subsequently also found to recognise the mouse ortho-
logue of SP-10, inhibits mouse in vitro fertilization [37].
Both of these antibodies inhibit human sperm penetra-
tion of zona-free hamster eggs. SP-10 as an immunogen
have been used for immunogenicity studies employing
different routes. Specific anti-SP-10 antibodies have been
measured in vaginal secretions of mice following oral
immunization with attenuated Salmonella sp. expressing
human SP-10 [38] and in oviductal fluid of macaques fol-
lowing intramuscular immunization [39]. Antibody levels
in the oviduct are of particular relevance since SP-10 is
localised with in the acrosomal compartment [40] and the
outer acrosomal membrane complex [41] and is therefore
only accessible to antibody after the acrosome reaction
has been initiated. SAMP14, a novel, human acrosome
membrane associated, GPI anchored member of the LY-6/
uPAR receptor superfamily has been characterized and
shown to have a role in sperm-egg interaction, antibodies
against SAPM14 inhibit both binding and fusion of
human sperm to zona free hamster eggs [17]. Panel of 2-
D composite images of human sperm proteins (Encyclo-
paedia of human sperm proteins) have been generated,
which are being characterized and are in a process of
developing target molecules to interfere the sperm egg
interaction with various strategies [42,43].
Testis specific lactate dehydrogenase LDH-C4 has been
well characterized. The sperm specific isozyme of lactate
dehydrogenase LDH-C4 was purified from mouse testis
and was shown to suppress the fertility of female mice,
rabbits, and baboon [44]. For the last two decades, LDH-
C4 has been reported to be an excellent antigen for use in
a contraceptive vaccine. In addition, synthetic peptide of
LDH-C4 has been shown to induce a contraceptive effect
as much as 75% following vaccination of female baboons
[45,46]. Independent fertility trials with same LDH-C4
peptide conjugated to a T-cell epitope from tetanus toxin
(TT) in non-human primates were carried out [47]. It was
demonstrated that in cynomolgus macaques, vaccination
with LDH-C4 did not reduce fertility.
Fertilization Antigen-1 (FA-1) is a sperm specific glycopro-
tein originally isolated from human and murine sperm
and was subsequently also found to be expressed on
sperm from rabbit, bull and macaque. The cDNA encod-
ing murine FA-1 [48] and human FA-1 [49] has been
cloned and sequenced. Antibodies to FA-1 inhibit in vitro
fertilization in all of the above species by interfering with
sperm zona interaction [50] and immunization of female
rabbits and mice with FA-1 does appear to reduce fertility
in vivo [51]. Novel human testis specific contraceptive vac-
cine antigen [20] was identified by subtracting single
stranded cDNA of human testis with poly(A+) RNA of
human peripheral blood cells. Rabbit recombinant CV
antibodies inhibited human sperm penetration of zona-
free hamster oocytes, as well as human sperm binding to
human oocyte zona pellucida [20,52]. Recently, testis spe-
cific antigen (TSA-1) expressed in murine sperm [53] and
human sperm [19] has been cloned and characterized. In
functional bioassays, recombinant TSA-1 antibodies
inhibited the acrosome reaction [19] and sperm egg bind-
ing in in vitro assays [53]. These findings indicated that the
testis/sperm specific protein has role in human sperm
function and may find clinical application in the contra-
ceptive vaccine development.
The MDC (Metalloprotease/Disintegrin/Cysteine-rich)
protein are a rapidly growing family of integral membrane
proteins, all of which contains a number of distinct con-
served feature including a metalloproteinase-like domain,
a Disintegrin-like domain, a Cysteine-rich domain, a pro-
domain and a transmembrane domain (also known as
ADAM family) [54]. ADAM family member expressed pre-
dominantly in the testis are fertilin β (ADAM2), cyritestin
(ADAM3; tMDC I), ADAM 5 (tMDC II), ADAM 6, ADAM
16 (xMDC 16), ADAM 18 (tMDC III), ADAM 20, ADAM
21, ADAM 24 (testase 1), ADAM 25 (testase 2), ADAM 26
(testase 3), ADAM 29 and ADAM 30. Five of these ADAMs
(fertilin β, cyritestin, ADAM 5, ADAM 16, ADAM 18) are
known to be expressed as proteins present on male germ
cells and/or mature sperm of at least one species. Other
ADAMs such as fertilin α (ADAM 1) is expressed in other
tissues but is also present on sperm [55].
Among the cell adhesion events that are mediated by
ADAMs are the interactions between mammalian gamete
plasma membranes during fertilization. On mouse
sperm, there are at least three ADAMs that appear to par-
ticipate in sperm-egg binding: fertilin α (ADAM1), fertilin
β (ADAM2), and cyritestin (ADAM3) [56]. Evidence for a
specific role of fertilin α in sperm-egg adhesion and/or
membrane fusion is not very clear. Fertilin α may have a
role in adhesion, as the fertilin α cysteine-rich domain
appear to participate on cell adhesion, as has also been
found for ADAM 12 [57]. A recombinant form of fertilin
α corresponding to the complete extracellular domain
(i.e.  the disintegrin-like domain, the cysteine-rich
domain, and the EGF-like repeat) inhibits sperm-egg
binding more effectively than does a shorter form with a
truncated disintegrin-like domain [58], suggesting that
the presence of disintegrin-like domain in recombinant
fertilin α enhances the ability of the recombinant fertilin
α protein to inhibit sperm-egg binding. With regards to
gamete fusion, CD9 on the egg appears to be critical (59–
61) although the mechanism of this protein's role in
membrane fusion is unclear. On the sperm, fertilin α was
originally speculated to have hydrophobic fusion peptide
[62] but in fact does not appear be required for sperm-eggReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/10
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fusion, as fertilin β-/-sperm lack fertilin α and are yet capa-
ble of sperm-egg fusion [63].
Fertilin β was one of the first "cellular disintegrins" iden-
tified and the best-characterized candidate molecule that
mediates sperm-egg membrane fusion. Fertilin β is one
subunit of the dimeric sperm antigen that cross reacts with
one of the fertilization inhibiting antibodies, known as
PH-30 (fertilin α is the other subunit) [64]. Fertilin β and
cyritestin have similar amino acid sequence in their disin-
tegrin loops. Based on studies with synthetic peptides and
anti-disintegrin loop antibodies, both fertilin β and cyrit-
estin appear to utilize their disintegrin loop sequence to
interact with the egg membrane [58,65]. Incubation of
mouse eggs with recombinant fertilin β prior to insemina-
tion inhibits sperm-egg binding during IVF [64]. Likewise,
incubation of sperm in antibodies against the disintegrin
domain of mouse fertilin β prior to insemination also
inhibits sperm-egg binding and fusion [65]. Anti-fertilin β
antibodies also reduced the incidence of fertilization of
rabbit eggs in vitro [64]. Finally, knockout male mice lack-
ing either fertilin β [67] or cyritestin [68] are severely sub-
fertile. Fertilin β-/- sperm show greatly reduced levels of
binding to the egg plasma membrane, sperm-egg fusion,
migration from the uterus into the oviduct and binding to
the egg-zona pellucida [67], but the few that bind are
capable of sperm-egg fusion. Cyritestin-/-  sperm show
reduced ability to bind to the eggs extracellular matrix and
the zona pellucida [68].
A number of glycoproteins on the surface of spermatozoa
are acquired from epididymal secretions during transit
through epididymis. It is quite likely that such proteins
may have either a protective role or a modulation role in
sperm maturation. Some have been specifically impli-
cated in sperm-egg interactions at fertilization such as
human gp 20 [69] and rat DE [70]. Protein DE (also
known as acidic epididymal glycoprotein, AEG) is a 37
kDa glycoprotein that associates with the dorsal region of
the sperm head during epididymal maturation. Antibody
to protein DE/AEG significantly inhibits sperm penetra-
tion in zona free eggs in in vitro assays.
Conclusion
In conclusion, candidate antigens have been, and are con-
tinuing to be, identified that have potential to interfere
with biological process that are fundamental to the repro-
ductive process, fertilization. It is evident from the studies
that the antibodies against the sperm specific antigen have
proved to be extremely effective at reducing sperm egg
interactions  in vitro. Immunizations of female subjects
with sperm specific proteins lead to block of fertility in
several animal models. One mechanism by which sperm
antigens may cause immunoinfertility is to induce anti-
body formation in the female reproductive tract and in
turn block single or multiple points of sperm and egg
interaction. Therefore, it may be possible, by using various
formulations in delivery vehicles with suitable carriers
and adjuvants and expression vectors to challenge the gut-
associated lymphatic tissues (GALT) for stimulation of B-
lymphocytes committed to local immunity in the repro-
ductive tract. This, in conjunction with a systematic vac-
cine, could ensure antibody existence at all sites where
spermatozoa could possibly transit in the female tract.
Recombinant DNA technology has made possible the
manipulation of the genetic material encoding sperm pro-
teins and in bioprocess development and product purifi-
cation have made available sufficient quantities of
recombinant proteins for immunogenicity and fertility
studies. Injections of recombinant and peptide vaccine
immunogens in various animal models including sub-
human primates have produced specific immune
responses. Thus, the theoretical basis for the emergence of
a contraceptive vaccine based upon recombinant proteins
or synthetic peptides are at hand, and initial results have
been promising. The technology underpinning vaccine
development is constantly being developed and the intro-
duction of DNA/RNA vaccines are certain to impact upon
the immunocontraception field. DNA/RNA vaccine has
several potential advantages: these are cheap and easy to
produce, can be easily modified and are quite stable as
compared to conventional vaccines. Current and emerg-
ing strategies-such as sperm proteomics, sperm protein
encyclopaedia (using 2D composite images of human
sperm proteins), structural biology of sperm proteins and
modelling of protein ligands interaction using X-ray and /
or NMR structures will provide experimental foundation
for the design of small molecule inhibitors for fertility
control. Moreover gene knockout and gene silencing
using RNA interference (RNAi) will provide better under-
standing of the molecular and biological process of sperm
function and sperm-egg interaction. This understanding is
required to generate clinical advances for treatment of
infertility and novel contraceptive targets.
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